$BSX with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for NYSE:BSX after a negative under reaction following its earnings release placing the stock in drift D with an expected accuracy of 83.33%.
85,935.48
0.01 BRL
7.96 B BRL
71.13 B BRL
About Boston Scientific Corporation
Sector
Industry
CEO
Michael F. Mahoney
Website
Headquarters
Marlborough
Founded
1979
ISIN
BRB1SXBDR006
FIGI
BBG00R3WYH83
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
BSX heads up at $86.01: Golden Genesis might end rocket trip3 charts show the same fibs in different tf's.
BSX has been a rocket ship for a while.
It has just hit a new Godlen Genesis fib.
The last one held it up for a few months.
It is POSSIBLE that we get a pullback here.
It is PROBABLE that we orbit this a few times.
It is PLAUSIBLE that we break and co
Morning Overview: Pullback and Anti Pattern's To Trade TodayThis morning I covered the overview of AMEX:SPY $AMEX:DIA. I talked about pattern recognition across markets, I gave valuable insight into potential pullbacks and anti patterns that are setting up. I provide entry ideas and mentioned the stocks that I like for trading today. Many of which were sho
Boston Scientific - interesting formationBSX share price looks like it will go more to the upside. Especially after BSX reported its 1Q 2024 financial results and lifted up full year 2024 financial guidance.
Another positive trigger will occur end of May - June as the company should announced completion of the acquisition of Axonics (AXNX)
Confirmed cup and handle pattern on BSX chartHi,
please see the following chart pattern, that has been confirmed in the last weeks.
Accordingly to the rules of the pattern, the price target is about 70$.
If doesn't will come a market crash, there is a good opportunity, to reach the TP.
The price action is supported with the AI hype, that is e
🏥💼 Boston Scientific (BSX) Investment Analysis 💡📈Strategic Acquisitions:
Boston Scientific's recent acquisitions, including Axonics, Relievant Medsystems, and partial offer for Acotec, signify its proactive expansion strategy, targeting new growth opportunities in medical segments and lucrative markets like China.
Innovative Product Introductions
BSX - Short IdeaI believe BSX had a good run up the past couple of weeks. And by looking at how its finding resistance at the top key levels, I expect to have a potential move down to $54 area. Again, risk management is key. Expected return vs risk is important. Always keep that in mind. The markets are choppy so y
$BSX Soars to Record Highs: A Compelling Investment Opportunity
With a recent surge to record highs, fueled by positive developments and robust financial performance, here's a compelling case for potential buyers to consider adding NYSE:BSX stock to their portfolios.
1. Technical Analysis: Riding the Rising Trend Channel
Boston Scientific is currently rid
Support ReachedThe high of October has been re-tested today. It serves as support now and is valid the more as is coincides with the 2 38% Fibonacci levels. A correction of the December decline seems to be likely.
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
BSX4801034
Boston Scientific Corporation 4.7% 01-MAR-2049Yield to maturity
5.57%
Maturity date
Mar 1, 2049
BSX4801033
Boston Scientific Corporation 4.55% 01-MAR-2039Yield to maturity
5.41%
Maturity date
Mar 1, 2039
BSX.GJ
Boston Scientific Corporation 7.375% 15-JAN-2040Yield to maturity
5.26%
Maturity date
Jan 15, 2040
BSX4988126
Boston Scientific Corporation 2.65% 01-JUN-2030Yield to maturity
5.08%
Maturity date
Jun 1, 2030
BSX4800733
Boston Scientific Corporation 4.0% 01-MAR-2029Yield to maturity
4.88%
Maturity date
Mar 1, 2029
BSX4602368
Boston Scientific Corporation 4.0% 01-MAR-2028Yield to maturity
4.86%
Maturity date
Mar 1, 2028
BSX4800732
Boston Scientific Corporation 3.75% 01-MAR-2026Yield to maturity
4.78%
Maturity date
Mar 1, 2026
BSX4988125
Boston Scientific Corporation 1.9% 01-JUN-2025Yield to maturity
4.71%
Maturity date
Jun 1, 2025
CH0A
AMERICAN MEDICAL SYSTEMS EUROPE B.V. 2022-08.03.34 GUARANTEEDYield to maturity
3.45%
Maturity date
Mar 8, 2034
Explore more bonds